A new dual-action medication to cause double-trouble for Tuberculosis

Tuberculosis is once again a threat to the world, especially due to the multi-drug resistant species that have infected around 500.000 humans world-wide in 2015 only. Treatment options for these patients are limited and expensive, and more dramatically, in some cases completely absent; clinicians have no cure for these patients. Using high resolution microscopy techniques we discovered that upon antibiotic treatment the DNA of Mycobacterium tuberculosis condenses into a single clump (Figure 1). Recovery from this condensed state turns out to be a not yet discovered weak spot of the bacteria. Importantly, by using this weak spot we could influence survival of the bacteria dramatically. This is a whole new approach in antibiotic treatment for these pathogenic mycobacteria, and as also other bacteria condense their DNA, the approach will be applicable for more pathogens


Click for more details on this licensing opportunity